did not show a clear trend after labor induction onset
in the GF group, resulting in a considerably lower
value than GS group at hour 4.
4 DISCUSSION
Labor induction has become a common practice in
obstetrics. The number of labor inductions has
increased significantly in recent years. Studies
explain that this rise is due to an increase in
medically indicated induction as well as an increase
in elective induction (Grobman, 2007). Despite this,
not all inductions have successful outcomes,
resulting in an increase in the rate of caesarean
section. It is important to know whether a woman
will reach or not a successful induction so that
clinicians may be able to better plan deliveries,
preventing maternal and fetal stress which can
appear in long induction processes.
In this study, it was analyzed the response of
misoprostol drug used for preinduction cervical
ripening not only with traditional obstetrical
indicators, but also with parameters that characterize
the resulting myoelectrical activity of the uterus. Our
data shows that 25 µg of Misoprostol with repeated
dose up to three administrations has similar efficacy
in terms of success rate in comparison with other
authors (Mayer, 2016). Accordingly to Mayer et al,
success inductions with 200 µg of misoprostol
occurred in 77.3% of the cases and our results shows
a 79.6% of success inductions.
In addition, for patients involved in the study,
the time between induction and delivery for success
group was 22.98 ± 10.8 h. Although this result does
not match with those of other authors (Papanikolaou
et al, 2004) who obtain a shorter value of time to
delivery 11.9 h, this could be explained because of
the different dose employed for labor induction.
Instead of 25µg of misoprostol, they used a 50µg
dose with repeated doses up to three times.
On the other hand, our results show that EHG
records have better performance in detecting uterine
contractions than TOCO records (627 vs. 324).
Given that nowadays the number of contractions is a
basic parameter to assess labor progress, this
technique could provide a better assessment in this
sense. This is also consistent with other studies that
have seen the limitations concerning to the use of
TOCO records for monitoring uterine dynamics in
other conditions (Euliano, 2009).
Concerning to the characteristics of the EHG, the
results of this work indicate that patients from GS
and GF experiment a different electrophysiological
response to the induction drug. Failure group, except
for contraction duration, did not show any clear
trend. In contrast, in success group a gradual
increase is evident in values of EHG-burst amplitude
as well as spectral parameters. These results suggest
that misoprostol, as an agent for the stimulation of
uterine activity, acts favoring the increase of cell
junctions (gap junction); thus increasing the total
number of active cells during EHG-burst (Garfield,
2007) and so the presence of more intense
contractions and an increased ratio of the cells’
excitability. In comparison with basal state,
significant changes in EHG characteristics begin to
show as early as about 90-120 minutes after
misoprostol administration. These results coincide
with other authors who have analyzed the effect of
misoprostol on uterine contractility (Arronson et al,
2004). This study reported that the first effect of
misoprostol is an increment in uterine tonus. Then
after 1-2 h, the tonus began to decrease and is
replaced by regular uterine contractions being the
uterine activity, measured in Montevideo units,
significantly greater after 2 h of misoprostol
administration. Moreover the time required to
manifest the changes in EHG characteristics when
inducing with misoprostol is coherent with the
pharmacokinetic studies (Tang, 2002). In such study
it was found that plasma concentration of
misoprostol gradually increases after 400µg of
vaginal administration and peak plasma
concentration is reached between 75 and 80 minutes.
After that, plasma concentration slowly decreases
and undetectable levels of drug are seen even after 6
h.
Furthermore, other authors have analyzed the
evolution of the EMG activity up to 12 hours after
administration of dinoprostone which is another
commonly drug used for labor induction (Aviram et
al, 2014). They found that uterine EMG activity,
defined as mean electrical activity of the uterine
muscle over a period of 10 minutes, did not change
significantly during the first two hours, and then
increased between 2 and 8 hours after dinoprostone
administration. Another study that analyzed the
EMG activity during labor induction with oxytocin
and dinoprostone (Toth, 2005), found statistically
significant difference in the uterine activity index
between successful and unsuccessful labor induction
after 210 minutes of labor induction onset In
comparison with our results, the uterus response to
misoprostol is faster than the response to
dinoprostone shown in those other studies. Other
authors have used DF2 parameter of EHG to analyze